RASSF5 and neoplasm: Our variants could function through two possible scenarios: (1) they could bind to Ras and compete with other Ras effectors that promote cancer, and (2) the variants could amplify the natural tumor suppressor function of RASSF5 through interactions with other proteins in tumor-suppressing pathways.